furosemide has been researched along with Respiration Disorders in 7 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassab, M | 1 |
| Khriesat, WM | 1 |
| Bawadi, H | 1 |
| Anabrees, J | 1 |
| Castellanos, D | 1 |
| Travelli, FC | 1 |
| Reyhan, I | 1 |
| Votava-Smith, JK | 1 |
| Ramanathan, A | 1 |
| Bar-Cohen, Y | 1 |
| Karabayir, N | 2 |
| Kavuncuoglu, S | 1 |
| Lewis, V | 1 |
| Whitelaw, A | 1 |
| Yazigi, R | 1 |
| Lerner, S | 1 |
| Tejani, N | 1 |
| Wiswell, TE | 1 |
| Rawlings, JS | 1 |
| Smith, FR | 1 |
| Goo, ED | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Fluid Management in Transient Tachypnea of the Newborn[NCT01225029] | 64 participants (Actual) | Interventional | 2008-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01225029)
Timeframe: every day until discharge, an average of approximately 8 days and a maximum of 12 days
| Intervention | calendar days (Mean) |
|---|---|
| Standard Fluids | 8 |
| Restricted Fluids | 7 |
(NCT01225029)
Timeframe: every hour until patient stable without respiratory support, an average of approximately 55 hours and a maximum of 205 hours
| Intervention | hours (Median) |
|---|---|
| Standard Fluids | 45 |
| Restricted Fluids | 42 |
(NCT01225029)
Timeframe: hour until first enteral feed achieved, an average of approximately 40 hours and a maximum of 100 hours
| Intervention | hours (Mean) |
|---|---|
| Standard Fluids | 31 |
| Restricted Fluids | 35 |
2 reviews available for furosemide and Respiration Disorders
| Article | Year |
|---|---|
Furosemide for transient tachypnoea of the newborn.
Topics: Administration, Oral; Cesarean Section; Female; Furosemide; Humans; Infant, Newborn; Injections, Int | 2013 |
Furosemide for transient tachypnea of the newborn.
Topics: Administration, Oral; Furosemide; Humans; Infant, Newborn; Randomized Controlled Trials as Topic; Re | 2002 |
2 trials available for furosemide and Respiration Disorders
| Article | Year |
|---|---|
Intravenous frusemide for transient tachypnoea of the newborn: a randomised controlled trial.
Topics: Diuretics; Double-Blind Method; Female; Furosemide; Humans; Infant, Newborn; Injections, Intravenous | 2006 |
Effect of furosemide on the clinical course of transient tachypnea of the newborn.
Topics: Female; Furosemide; Humans; Infant, Newborn; Male; Respiration Disorders | 1985 |
3 other studies available for furosemide and Respiration Disorders
| Article | Year |
|---|---|
Acute Aortic and Mitral Valve Perforations Caused by Granulomatosis With Polyangiitis.
Topics: Acute Disease; Anemia; Anti-Bacterial Agents; Aortic Valve; Child; Combined Modality Therapy; Diagno | 2015 |
Intravenous furosemide therapy in transient tachypnea of the newborn.
Topics: Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up St | 2010 |
Association of acute pyelonephritis with pulmonary complications in pregnancy. A report of two cases.
Topics: Adult; Ampicillin; Anemia, Hemolytic; Cefoxitin; Female; Furosemide; Humans; Pregnancy; Pregnancy Co | 1990 |